Accessibility Menu
Zentek logo

Zentek(TSXV) ZEN

Current PriceCA$0.78
Market CapCA$98.76MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)+28%
5 Year-75%
1 Year-38%
1 Month+44%
Zentek last closing stock price
MetricPriceDate
Last closeCAD 0.782026-07-23
Zentek stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+20%CAD 0.652026-07-16
1 month+44.44%CAD 0.542026-06-23
3 month+20%CAD 0.652026-04-24
Year to date-12.36%CAD 0.892025-12-31
1 year-38.1%CAD 1.262025-07-23
3 year-63.38%CAD 2.132023-07-24
5 year-74.59%CAD 3.072021-07-23
Since inception+27.87%CAD 0.612010-12-23

Zentek Financials at a Glance

Market Cap

CA$98.76MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$166.05K

Net Income (TTM)

-CA$9.77M

EPS (TTM)

-CA$0.09

P/E Ratio

-8.49

Dividend

CA$0.00

Beta (Volatility)

0.97 (Low)

Price

CA$0.78

Volume

262,344

Open

CA$0.76

Previous Close

CA$0.78

Daily Range

CA$0.72 - CA$0.78

52-Week Range

CA$0.52 - CA$1.70

Estimated Earnings Date

Jul 1, 2026

ZEN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zentek

Zentek Ltd. is a Canadian company specializing in the exploration and advancement of graphene and related nanomaterials. The firm is known for its innovative ZenGUARD brand, which features a graphene-based antimicrobial coating used in various products, including surgical masks and HVAC filters.

Products and Services
  • Graphene-based antimicrobial coatings for personal protective equipment
  • Point-of-care diagnostics leveraging graphene compounds
  • Synthesis of graphene, graphene oxide, and quantum dots for diverse applications
Growth Outlook
  • Expansion into healthcare markets with innovative graphene applications
  • Increased demand for antimicrobial solutions amid global health concerns
  • Strategic partnerships to enhance product development and market reach
Financial Highlights
  • Recent quarterly revenue of CAD 36,767, showing potential for growth
  • Trailing twelve months (TTM) revenue of CAD 81,359, indicating upward momentum
  • Cash and cash equivalents of CAD 1,302,738, providing operational stability
Zentek Ltd. operates in the medical instruments and supplies industry, focusing on innovative solutions that leverage the unique properties of graphene. The company's flagship product, ZenGUARD, is gaining traction in the market due to its effectiveness as an antimicrobial agent. As global health concerns continue to rise, the demand for such products is expected to increase, positioning Zentek favorably for future growth. The company's financial performance reflects a commitment to research and development, with significant investments aimed at expanding its product offerings. Despite recent losses, the revenue trajectory suggests potential for recovery and growth. The cash reserves provide a buffer for ongoing operations and development initiatives, allowing the company to navigate challenges while pursuing strategic opportunities. Overall, Zentek Ltd. presents an intriguing opportunity for investors interested in innovative healthcare solutions and the growing field of nanotechnology. The company's focus on graphene applications positions it well within a rapidly evolving market, making it a noteworthy consideration for those looking to invest in the future of healthcare technology.
AI Generated • Jul 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10

CEO

Mohammed Jiwan

Website

www.zentek.com

Headquarters

Guelph, ON P7B 6M4, CA

ZEN Financials

Key Financial Metrics (TTM)

Gross Margin

-2519.08%

Operating Margin

-6322.76%

Net Income Margin

-5882.61%

Return on Equity

-81.71%

Return on Capital

-92.44%

Return on Assets

-64.74%

Earnings Yield

-11.78%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$98.76MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

126.62M

Volume

262.34K

Avg. Volume

270.46K

Financials (TTM)

Gross Profit

-CA$4.18M

Operating Income

-CA$10.50M

EBITDA

-CA$9.69M

Operating Cash Flow

-CA$5.07M

Capital Expenditure

-CA$552.89K

Free Cash Flow

-CA$5.62M

Cash & ST Invst.

CA$1.30M

Total Debt

CA$1.91M

Zentek Performance Analysis

Zentek annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 72,855-78.6%
20242024-03-31CAD 29,816-59.1%
20252025-03-31CAD 872,4952826.3%
20262026-03-31CAD 166,048-81.0%
Zentek sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-92.9%
Q22025-09-30-89.3%
Q32025-12-31952.2%
Q42026-03-31-43.7%
Zentek annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -0.15-57.9%
20242024-03-31CAD -0.12-19.7%
20252025-03-31CAD -0.10-16.2%
20262026-03-31CAD -0.09-5.4%
Zentek sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-3026.1%
Q22025-09-30-53.8%
Q32025-12-31-16.5%
Q42026-03-31-40.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CA$36.77K

-95.5%

Gross Profit

-CA$2.93M

-636.8%

Gross Margin

-79.74%

N/A

Market Cap

CA$98.76MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$9.88M

N/A

Employees

10

N/A

Net Income

-CA$3.53M

-91.7%

EBITDA

-CA$3.72M

-97.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CA$1.30M

+972.4%

Total Debt

CA$1.91M

+181.1%

Accounts Receivable

CA$371.25K

-69.1%

Inventory

CA$417.55K

-53.0%

Long Term Debt

CA$1.75M

+982.8%

Short Term Debt

CA$161.74K

-68.8%

Return on Assets

-64.74%

N/A

Return on Invested Capital

-90.87%

N/A

Free Cash Flow

-CA$909.31K

+29.1%

Operating Cash Flow

-CA$734.92K

+42.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RX.VBioSyent Inc.
CA$14.69+1.03%
MDNA.TOMedicenna Therapeutics Corp.
CA$0.35-1.43%
CRDL.TOCardiol Therapeutics Inc.
CA$1.74-4.40%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
AALAmerican Airlines Group
$13.56-0.08%
TAT&T
$22.96-0.00%
ONDSOndas
$7.93-0.01%

Questions About ZEN

What is the current price of Zentek?

Zentek is trading at CA$0.78 per share.

What is the 52-week range for Zentek?

Over the past 52 weeks, Zentek has traded between CA$0.52 and CA$1.70.

How much debt does Zentek have?

As of the most recent reporting period, Zentek reported total debt of CA$1.91M.

How much cash does Zentek have on hand?

Zentek reported CA$1.30M in cash and cash equivalents in its most recent financial results.

What is Zentek’s dividend yield?

Zentek does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services